chrisvoncsefalvay/vaers-outcomes huggingface dataset:
feeling chill; Fever; Headache; This case was reported by a consumer and described the occurrence of chilliness in a adult patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On 1st January 2020, the patient received Shingles vaccine. On 1st January 2020, less than a day after receiving Shingles vaccine, the patient experienced chilliness, fever and headache. On an unknown date, the outcome of the chilliness, fever and headache were unknown.   It was unknown if the reporter considered the chilliness, fever and headache to be related to Shingles vaccine.  Additional details were reported as follows: The age at vaccination was not reported. The age group was not reported but it was selected as adult as per the vaccine indication. The patient took a shingle vaccine shot in morning and feeling chill, fever and headache. The patient asked if Ibuprofen or Tylenol would help for treatment.
Got my first 2 Moderna shots and had no adverse reaction. Then over 6 months late I got my Moderna booster. At first I did not have an adverse reactions. Then about 12 days later my scalp started itching uncontrollably. Then my back was itching? then my neck? then everywhere. I was itching and scratching so much I could not sleep. I took an allergy pill and it subsided. Then it came back the next day. I took another allergy pill. I thought it would go away but now it?s two weeks and I?m uncontrollably scratching everywhere and I have chronic urticaria and dermatographia with no end in sight.
About 24 hours later after 2nd dose, I started out with just a cough. Cough got worse and had shallow breathing I went to the local walk-in clinic. They put me on two inhalers and it has got progressively worse. I then called in Dr. on 01/06/2022 and he prescribed Methylprednisolone 4mg
Fever - started at 100.1 and reached 102.4 by 7am.  Severe chills  Joint and body ache Severe headache
had hives for another 4 months; severe allergies; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team, Program ID. The reporter is the patient.  A 68-year-old female patient received BNT162b2 (BNT162B2), as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1), for COVID-19 immunization, reaction(s): "she had scaly rash all over her neck for 4 or 5 months", "severe allergies", "they were not sure if her throat would close". The following information was reported: URTICARIA (non-serious), outcome "unknown", described as "had hives for another 4 months"; HYPERSENSITIVITY (non-serious), outcome "unknown", described as "severe allergies".  Additional information: With the second dose of the Pfizer COVID-19 Vaccine the caller stated that she had hives for another 4 months.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Muscle aches, fever 100.5 was the highest, headache and nausea, lasted a day and a half. Took Tylenol for fever and pains which did break my fever. Last night, 6/18/2020 I noticed a rash on my chest just between my breasts. Still there today 6/19/2020                      l
Focused Assessment: Presents alone as referral from Occupational Health for further eval. Patient had flu vaccine yesterday and one hour later developed nausea with vomiting. Currently has flushed face, body aches, and nausea.
headache after 2nd dose; This is a spontaneous report from a Pfizer-sponsored program. A contactable male consumer (patient) reported that a male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, lot number and expiration date was not reported), via an unspecified route of administration on 19Feb2021 as dose 2, single for COVID-19 immunisation. The patient's medical history included pain in extremity after first dose from an unknown date and unknown if ongoing. Concomitant medications included ibuprofen, paracetamol taken for an unspecified indication, start and stop date were not reported. Previously patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, lot number and expiration date were not reported), via an unspecified route of administration, on 29Jan2021 as dose 1, single for COVID-19 immunization. On an unspecified date in 2021, the patient experienced light headache after 2nd dose. The outcome of event was unknown.  Follow-up attempts completed. No further information expected.
p/vax pt noticing redness @ Td site;progressed to redness whole upper rt arm & induration & swelling;pt instructed to go see MD;
Doc thinks sterile abscess 1/3/2014 warm, swollen, painful whole left upper arm.
Pt states had the expected soreness after the vaccine, then had shooting pain to the shoulder area starting on 11-11-2015 while playing basketball. Shooting pain continued if pt moves arm. At rest there is no pain. Region where the shot was given looks normal per pt. Pt states no history of unexpected reactions getting previous flu vaccines or any other vaccines.
2 seizures; Severe headache; Swollen glands; Weakness in left arm; Pins and needles sensation in the left arm; Blurred vision; Ringing in both ears; Pain; Unable to turn their head/ Head immobility; Inability to move left arm/ Arm immobility; This serious case was reported by a consumer via call center representative and described the occurrence of seizure in a female patient who received Herpes zoster (Shingrix) (batch number 5SC3X) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced seizure (Verbatim: 2 seizures) (serious criteria GSK medically significant), headache (Verbatim: Severe headache), swollen glands (Verbatim: Swollen glands), weakness of arms (Verbatim: Weakness in left arm), pins and needles (Verbatim: Pins and needles sensation in the left arm), blurred vision (Verbatim: Blurred vision), ringing in ears (Verbatim: Ringing in both ears), pain (Verbatim: Pain), head discomfort (Verbatim: Unable to turn their head/ Head immobility) and mobility decreased (Verbatim: Inability to move left arm/ Arm immobility). Shingrix was discontinued (Dechallenge was positive). The outcome of the seizure, headache, swollen glands, weakness of arms, pins and needles, blurred vision, pain, head discomfort and mobility decreased were resolved and the outcome of the ringing in ears was not resolved.   It was unknown if the reporter considered the seizure, headache, swollen glands, weakness of arms, pins and needles, blurred vision, ringing in ears, pain, head discomfort and mobility decreased to be related to Shingrix.     It was unknown if the company considered the seizure, headache, swollen glands, weakness of arms, pins and needles, blurred vision, ringing in ears, pain, head discomfort and mobility decreased to be related to Shingrix.   Additional Information: GSK receipt date:04-Apr-2023 The patient was the reporter. The reporter reported experiencing numerous adverse reactions, after dose of Shingrix. The reporter was experiencing a severe headache, two seizures, swollen glands, inability to move left arm and weakness in left arm. The reporter also had pins and needles sensation in the left arm. The reporter was unable to turn head for a period of time and had blurred vision.  The reporter also had ringing in both ears.  The reporter said all symptoms resolved between 3 weeks to 2 months after first dose, with the exception of the ringing in the ears. The health care professional (HCP) advised not to receive second dose of Shingrix. The reporter did not consent to follow up. This case had been linked with US2023049707 reported by the same reporter.; Sender's Comments:  US-GSK-US2023049707:Same report, other patient
This report dexribes the occurrence of a food allergy in a 4-month-old male who received diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed (Infanrix).  This report was received from the subject's mother and has not been verified by a physician or other healthcare professional.  The subject had no reported medical history, concurrent conditions, or concurrent medications.  On approximately 07/19/2001, the subject received his first injection of Infanrix.  On this same date, the subject also received his second injection of hepatitis B vaccine recombinant (Engerix -B) and an injection of Haemophilus influenzae type b conjugate vaccine (manufacturer unknown).  Two months later, he was reported to have "dropped the charts" and to have developed "serious" food allergies.  As of 10/04/2002, the events reportedly persisted.
I am very in-tune with my body and my female cycle and, although I've experienced PMS symptoms since I began menstruating 13 years ago, I always know what to expect every month. Since receiving the first dose of the vaccine, I've been experiencing symptoms that I've never had in my life. These symptoms include: worsened PMS symptoms, PMS symptoms beginning earlier than usual, longer than usual cycle (40 days vs the average 32 days for my body), longer than usual menstruation (8 days vs the average 4 days for my body), debilitating pain in my ovaries that radiates down my hips and lower back, painful period (I typically look forward to my period as this usually alleviates my symptoms, but now they've been getting even worse once menstruation begins), flushing of the face, hot flashes followed by feeling extremely cold, feeling faint at times; tingling in my face, neck, and hands. These symptoms have been ongoing and progressively worsening as the time goes on since getting the vaccine. On 8/4/2021 I went to see the doctor for the first time following an extremely painful cycle where I could barely even move or eat. She ran tests, which came back negative, and prescribed me medication to help alleviate the pain. I returned today, 9/3/2021 to address continued symptoms as well as new symptoms. The clinic obtained bloodwork and the doctor recommended that I report my symptoms to VAERS as other patients have come in with similar issues following vaccination.
9 days after 1st shot I got up to use the bathroom in the middle of the night and fell to the ground, my ears were ringing so loud it was like church bells!  I couldn?t walk or move, i noticed my balance has been off for a week or so and didn?t think anything of it until this happened.  Still have ringing in both ears although the right one is the bad one.  I was diagnosed with Ménière?s disease yesterday.  I still can?t hear well out of right ear.  The dizziness is lessened but not gone.
Allergic reaction hives redness and swelling of head and face  Now experiencing this when using hair bleach after vaccine. Have previously  used this for years and now I have hives and redness when using familiar products
Information has been received from a registered nurse concerning a 27 year old female with no illness at the time of vaccination, and no drug reactions/allergies, and a history of postpartum cardiomyopathy, and fibromyalgia who on 13-DEC-2006 was vaccinated with a dose of Pneumovax 23 (lot # 655588/0883F) IM in the right deltoid at 1 PM.  Concomitant therapy included SYNTHROID, TOPROL XL TABLETS, DIOVAN, montelukast sodium (MSD), ZYRTEC, and NASACORT.  On 13-DEC-2006, the patient reported that the shot "hurt".  On 14-DEC-2006, the patient developed a fever of 104 degrees and also had a welt on her arm which was vaccinated.  The patient sought medical attention.  The patient was seen on 18-DEC-2006 in the evening, and the welt had decreased as well as her fever, however the patient's arm was still sore and tender.  The patient was treated with ROCEPHIN.  At the time of reporting, the patient was recovering.  Additional information was received from the registered nurse.  On an unspecified date, the patient recovered.  No additional information is expected.
Pt had knot on right thigh. Started fever on 4/30/03. Told Pt's mom to give Benadryl and Tylenol.
Information has been received from a female physician of unknown age (who also was the patient) via a field representative referring to herself. The patient's pertinent medical history and drug reactions/allergies were not reported. On an unknown date, the patient's sister was vaccinated with ZOSTAVAX (dose, route and lot# were not reported. The patient's concomitant therapy included prednisone (manufacturer unknown). On an unspecified date, after her sister received ZOSTAVAX, the patient was in the car with her sister "for a couple hours", the patient developed shingles (secondary transmission), which was diagnosed by herself. The patient's sister did not develop shingles after receiving ZOSTAVAX. Unspecified treatment was given for the adverse event. The outcome of the event was reported as recovering. The causality assessment between the events and ZOSTAVAX was not provided. Additional information has been requested.
Obviously, he wants to treat this and has never pain like electric shocks all over body.; Obviously, he wants to treat this and has never pain like electric shocks all over body.; a rash that started on his leg/It is spreading all over his chest, legs, armpits, groin and torso.; This is a spontaneous report from a contactable consumer (patient). A 37-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported, Expiry date : unknown), dose 1 via an unspecified route of administration on 14Apr2021 as dose 1, single for covid-19 immunisation. Age at vaccination was 37-year-old. Medical history included covid-19 and sick. He very sick with covid 19 a year before that. He clarified about 12 months prior to receiving the vaccine. No prior Vaccinations (within 4 weeks). He not really allergic to anything. He thought he came in contact with poison ivy but he did not. There were no concomitant medications. Caller stated he is a physical therapist calling about the covid 19 vaccine. He talked to someone at the (Department name withheld) to report and the CDC. Ever since the injection, since the first one he has had a rash that started on his leg. The patient experienced a rash that started on his leg/it is spreading all over his chest, legs, armpits, groin and torso on Apr2021. It was two days after the first injection 14Apr2021 about on 15Apr2021 or 16Apr2021 he noticed the rash. He first noticed it midday on his shins and didn't think much of it. He waited a little longer between the first and second doses. Treatment stated he had seen a dermatologist and has done courses of steroids and topicals and nothing helps. It was ongoing and has worsened. Caller does not have at this time. He did two different courses of prednisone and it helped at the start and a lotion, creams, which were also steroids. It kind of tames it but then it came straight back. Advised caller to follow up with primary care physician or local health care provider for treatment recommendations and medical advice. The patient obviously, wants to treat this and has never pain like electric shocks all over body on an unspecified date. He has seen his local health provider. One of his friends had same side effects and all over his arms and legs. Caller stated he will tell him about reporting but that's up to him. Caller declined to complete report on behalf of his friend. No further details provided. They can't prescribe any more steroids and is there something Pfizer is doing as far as treatment and research. The outcome of event rash was not recovered and other events was unknown.  Information about lot/batch number has been requested.
This spontaneous report has been received from a pharmacist referring to a 52 years old female patient. Information about concurrent condition, concomitant medication and medical history was not provided. On an unknown date, the patient started therapy with VALTREX (strength, dose, frequency, route, lot#, expiration date and indication were not reported). On 11-AUG-2017, the patient was vaccinated with a dose of ZOSTAVAX (route, lot# and expiration date were not reported), for prophylaxis while still taking VALTREX. No adverse effects were reported.
Dizzy; tingling down arm into fingers; Back pain; pressure on chest; pain in arm of injection; Headache; nausea; fever; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizzy), PARAESTHESIA (tingling down arm into fingers), BACK PAIN (Back pain), CHEST DISCOMFORT (pressure on chest) and VACCINATION SITE PAIN (pain in arm of injection) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 09-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Jun-2021, the patient experienced DIZZINESS (Dizzy), PARAESTHESIA (tingling down arm into fingers), BACK PAIN (Back pain), CHEST DISCOMFORT (pressure on chest), VACCINATION SITE PAIN (pain in arm of injection), HEADACHE (Headache), NAUSEA (nausea) and PYREXIA (fever). At the time of the report, DIZZINESS (Dizzy), PARAESTHESIA (tingling down arm into fingers), BACK PAIN (Back pain), CHEST DISCOMFORT (pressure on chest), VACCINATION SITE PAIN (pain in arm of injection), HEADACHE (Headache), NAUSEA (nausea) and PYREXIA (fever) outcome was unknown.            No relevant concomitant medications were reported.  No treatment information was provided.   This case was linked to MOD-2021-216479 (Patient Link).
Fever hallucination took nyquil to get to sleep.  Still not great next morning.  OK within 24 hours
Patient was suppose to get a Flu-shot in one arm and a Covid Bivalent Booster shot in the other arm.  Patient was given a Covid Bivalent Booster in each arm by mistake.  No known adverse effect to the patient have occurred at this time.
a lot of headache; tired; wanted to throw up; dizzy; cold; neck pains; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (a lot of headache), FATIGUE (tired), NAUSEA (wanted to throw up), DIZZINESS (dizzy) and NASOPHARYNGITIS (cold) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0231A904) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Mar-2021, the patient experienced HEADACHE (a lot of headache), FATIGUE (tired), NAUSEA (wanted to throw up), DIZZINESS (dizzy), NASOPHARYNGITIS (cold) and NECK PAIN (neck pains). On 24-Mar-2021, DIZZINESS (dizzy) had resolved. At the time of the report, HEADACHE (a lot of headache), FATIGUE (tired), NAUSEA (wanted to throw up), NASOPHARYNGITIS (cold) and NECK PAIN (neck pains) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant products reported  No treatment products reported
This spontaneous report as received from a consumer as part of a marketing research program refers to her/his friend, an approximately 74 year old male patient with decreased immune responsiveness. The patient's medical history included a melanoma tumor recently removed. On an unknown date, in approximately 2013, the patient was vaccinated with the first dose of ZOSTAVAX, injection (route of administration, anatomical location, lot number and expiration date were not reported). There were not concomitant medications provided. On an unspecified date, in 2013, the patient experienced shingles soon after getting the vaccine. The patient received a doctor's evaluation. The patient was incapacitated because of shingles (on his waist) and the rash took so long to fade. The outcome of shingles was reported as recovering/resolving since 4 or 6 months ago. The reporter considered shingles to be related to ZOSTAVAX. The reporter considered shingles to be an other medically significant event. Additional information has been requested.
throat hurting a little like soreness / Sore throat; sniffles; This spontaneous case was reported by a consumer and describes the occurrence of RHINORRHOEA (sniffles) and OROPHARYNGEAL PAIN (throat hurting a little like soreness / Sore throat) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination.     No medical history reported.    On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, the patient experienced RHINORRHOEA (sniffles). On 08-Feb-2021, the patient experienced OROPHARYNGEAL PAIN (throat hurting a little like soreness / Sore throat). On 07-Feb-2021, RHINORRHOEA (sniffles) had resolved. At the time of the report, OROPHARYNGEAL PAIN (throat hurting a little like soreness / Sore throat) outcome was unknown. Not Provided   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant product use was not provided by the reporter.  No treatment medication was reported.   Most recent FOLLOW-UP information incorporated above includes: On 08-Feb-2021: No specific follow-up information recorded.
reaction on her arm 48 hours after the injection; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of SKIN REACTION (reaction on her arm 48 hours after the injection) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. In January 2021, the patient experienced SKIN REACTION (reaction on her arm 48 hours after the injection). At the time of the report, SKIN REACTION (reaction on her arm 48 hours after the injection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant and treatment medication provided   Most recent FOLLOW-UP information incorporated above includes: On 20-Jan-2021: Non-Significant follow-up received on 20-JAN-2021.
Initial report received from a health care professional on 01 May 2007.  A 3 month old, male patient (with no known allergies) developed a 1/2" long brown pigment discolouration to the skin surrounding the injection site, after he received Tripedia (lot number reported "41813AB") intramuscularly, in the right thigh; IPOL (lot number Z0306) subcutaneously, in the left thigh; Prevnar (Wyeth, lot number 808684D) intramuscularly, in the right thigh and Combivax (Merck, lot number 0010F) intramuscularly, in the left thigh on 02 March 2007.  The symptoms occurred in the right thigh.  It was reported both puncture marks were still visible.  There was no nodule, no tenderness and no systemic effects.  He did not have any laboratory or diagnostic tests performed.  At the time of the vaccinations, he did not have any illness.  Prior to hospital discharge at birth, he was given Hep B vaccine (manufacturer, lot number, route and site of administration unknown).  At the time of the report, he had not recovered.
Systemic: Chest Tightness / Heaviness / Pain-Severe, Systemic: Tachycardia-Severe